ClinicalTrials.gov
ClinicalTrials.gov Menu

SBIRT Intervention for Gambling Behaviors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03287583
Recruitment Status : Active, not recruiting
First Posted : September 19, 2017
Last Update Posted : February 6, 2019
Sponsor:
Information provided by (Responsible Party):
Christopher Welsh, University of Maryland

Brief Summary:
Disordered gambling, like substance misuse, has been associated with various medical problems and adverse health outcomes. The Maryland Center of Excellence on Problem Gambling, along with experts in the fields of disordered gambling and behavior change, will work with the Maryland State Department of Health and Mental Hygiene's Behavioral Health Administration to develop a problem gambling-specific Screening, Brief Intervention and Referral to Treatment (SBIRT) intervention targeting individuals receiving medical care in general primary care clinics. The investigators will evaluate the feasibility and acceptability of inserting the problem gambling intervention in to preexisting substance use SBIRT services being provided in clinics in the state. In addition, the investigators will establish a clinic prevalence for gambling and finally, conduct a randomized trial using the problem gambling SBIRT intervention to see if it is effective in helping patients reduce their problematic gambling behaviors.

Condition or disease Intervention/treatment Phase
Gambling Disorder Behavioral: SBIRT for Gambing Other: Enhanced Control Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: participants will be randomized to receive either the Gambling Specific SBIRT Intervention or enhanced control.
Masking: None (Open Label)
Masking Description: No masking
Primary Purpose: Treatment
Official Title: Pilot Randomized Control Trial of an SBIRT Intervention for Gambling
Actual Study Start Date : January 2016
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : October 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: SBIRT
SBIRT intervention for Gambling
Behavioral: SBIRT for Gambing
The SBIRT intervention uses a brief gambling screening assessment to determine whether or not a participant is at risk for problem gambling. This is followed by a structured short brief intervention to assist people in better understanding their risk for gambling and what they can do to limit that risk.

Control
Participants randomized to the enhanced control condition will receive a handout with gambling resources.
Other: Enhanced Control
Participants randomized to the enhanced control condition will receive a handout with gambling resources.




Primary Outcome Measures :
  1. gambling time back follow-up [ Time Frame: one month ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adults
  • Attending the recruitment clinic at University of Maryland
  • English Speaking

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03287583


Locations
United States, Maryland
University of Maryland Medical Center, Midtown Campus
Baltimore, Maryland, United States, 21210
Sponsors and Collaborators
University of Maryland

Responsible Party: Christopher Welsh, Associate Professor, University of Maryland
ClinicalTrials.gov Identifier: NCT03287583     History of Changes
Other Study ID Numbers: HP-00067608
First Posted: September 19, 2017    Key Record Dates
Last Update Posted: February 6, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Gambling
Disruptive, Impulse Control, and Conduct Disorders
Mental Disorders